Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol‐associated hepatitis

Kunpeng Hu, Maria C. Perez‐Matos, Josepmaria Argemi, Eduardo Vilar‐Gomez, Irina Shalaurova, Esther Bullitt, Lee Landeen, Go Sugahara, Huiyan Deng, Karan Mathur, Stephanie Tran, Huimei Cai, Hanchang He, Yusuf Yalcin, Joana Vieira Barbosa, Meritxell Ventura‐Cots, Katherine Marx, Aniket P. Gad, Sebastian Niezen, Sofia Izunza Barba, Lay‐Hong Ang, Yury V. Popov, Zachary Fricker, Michelle Lai, Michael Curry, Nezam Afdhal, Gyongyi Szabo, Kenneth J. Mukamal, Arun J. Sanyal, James D. Otvos, Raza Malik, Takeshi Saito, Margery A. Connelly, Naga P. Chalasani, Ramon Bataller, Z.

Increased Expressions of Programmed Death Ligand 1 and Galectin 9 in Transplant Recipients Who Achieved Tolerance After Immunosuppression Withdrawal

Nguyen Hai Nam, Kojiro Taura, Yukinori Koyama, Takahiro Nishio, Gen Yamamoto, Yusuke Uemoto, Yusuke Kimura, Li Xuefeng, Daichi Nakamura, Kenji Yoshino, Eri Ogawa, Tatsuya Okamoto, Atsushi Yoshizawa, Satoru Seo, Keiko Iwaisako, Tomoaki Yoh, Koichiro Hata, Toshihiko Masui, Hideaki Okajima, Hironori Haga, Shinji Uemoto, Etsuro Hatano – 15 October 2021 – Programmed death 1 (PD1)/its ligand PD‐L1 concomitant with T cell immunoglobulin and mucin domain‐containing protein 3 (TIM‐3)/its ligand galectin 9 (Gal‐9) and the forkhead box P3 (FOXP3) might be involved in tolerance after liver transpl

Genome‐wide analysis identifies gallstone‐susceptibility loci including genes regulating gastrointestinal motility

Cameron J. Fairfield, Thomas M. Drake, Riinu Pius, Andrew D. Bretherick, Archie Campbell, David W. Clark, Jonathan A. Fallowfield, Caroline Hayward, Neil C. Henderson, Andrii Iakovliev, Peter K. Joshi, Nicholas L. Mills, David J. Porteous, Prakash Ramachandran, Robert K. Semple, Catherine A. Shaw, Cathie L. W. Sudlow, Paul R. H. J. Timmers, James F. Wilson, Stephen J. Wigmore, Athina Spiliopoulou, Ewen M. Harrison – 14 October 2021

Subscribe to